Glenmark UpBEAT As Tech Yields First Oncology Lead
This article was originally published in PharmAsia News
Executive Summary
Glenmark has scored a significant win in its search for potent candidates to treat cancers. Its BEAT platform technology has successfully combined two antibodies that could potentially be superior to existing therapies.